Related Experiment Video
Updated: May 28, 2026
13:27
Osteopathic Manipulative Treatment as a Useful Adjunctive Tool for Pneumonia
Published on: May 6, 2014
Vitamin D supplementation for severe pneumonia--a randomized controlled trial
Nidhi Choudhary1, Piyush Gupta
1Department of Pediatrics, University College of Medical Sciences and Guru Teg Bahadur Hospital, Dilshad Garden, Delhi, India.
Indian Pediatrics
|October 14, 2011
Summary
Short-term oral vitamin D supplementation did not improve severe pneumonia recovery in children under five. Further research with higher doses or longer durations is needed to confirm these findings.
Area of Science:
- Pediatric infectious diseases
- Nutritional immunology
- Respiratory medicine
Background:
- Severe pneumonia is a leading cause of mortality in children under five.
- Vitamin D plays a crucial role in immune function and may influence respiratory infections.
- Evidence on vitamin D supplementation for severe pneumonia treatment is limited.
Purpose of the Study:
- To evaluate the efficacy of oral vitamin D supplementation in resolving severe pneumonia in young children.
- To assess the impact of vitamin D on key clinical outcomes, including hospitalization duration and symptom resolution.
Main Methods:
- A randomized, double-blind, placebo-controlled trial was conducted with 200 children aged 2 months to 5 years diagnosed with severe pneumonia.
- Participants received either oral vitamin D (1000-2000 IU daily) or a placebo for 5 days, alongside standard antibiotic treatment and supportive care.
- Primary outcome was time to resolution of severe pneumonia; secondary outcomes included duration of hospitalization and time to resolution of specific symptoms.
Main Results:
- No significant difference was observed in the median time to resolution of severe pneumonia between the vitamin D and placebo groups (72 vs. 64 hours).
- Duration of hospitalization and time to resolution of tachypnea, chest retractions, and inability to feed were comparable in both groups.
- Short-term vitamin D supplementation showed no beneficial effect on the studied outcomes.
Conclusions:
- Current evidence suggests that short-term oral vitamin D supplementation (1000-2000 IU daily for 5 days) is not effective in treating severe pneumonia in children under five.
- Further investigation with higher vitamin D doses or extended supplementation periods may be warranted to fully elucidate its potential role.
- The findings highlight the need for robust clinical trials to guide therapeutic strategies for severe pneumonia in pediatric populations.
Related Concept Videos
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Pneumonia V: Nursing management and Prevention
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:29Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...